DGX 250117 150.00P (DGX250117P150000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

DGX250117P150000

Watchlist

1.05
-0.50-32.26%

15min DelayClose Jan 6 16:00 ET

1.05High0.75Low

Intraday

5D
Daily

News

Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
Kevin Travers16:22 ET
Tesla To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga11:28 ET
This Boeing Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
BenzingaJan 6 10:58 ET
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Kevin TraversJan 6 10:52 ET
Citi's Themes: Top Stocks in AI, Leisure, Fin-tech, Video Gaming, Etc. Vs. Their SA Quant Ratings
Seeking AlphaJan 6 09:59 ET
Quest Diagnostics Incorporated (NYSE:DGX) Might Not Be As Mispriced As It Looks
Simply Wall StJan 6 08:32 ET

Comments

ForeverBean

Jun 1, 2024 04:19

$Quest Diagnostics (DGX.US)$ PathAI + Invigorate + stable finance + qualified management team + decent PE.
Will it dominate pathology and cancer diagnosis with AI in the future? Worth noting.

Moomoo AI

Jan 11, 2024 05:10

Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.

Returns On Capital At Quest Diagnostics (NYSE:DGX) Have Stalled

Moomoo AI

Jan 8, 2024 08:01

The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.

Press Release: Quest Diagnostics Acquires Select Assets of Outreach Lab Services Business of Steward Health Care System

Moomoo AI

Dec 20, 2023 06:39

The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.

Press Release: Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

Moomoo AI

Dec 6, 2023 04:43

Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.

Quest Diagnostics Incorporated's (NYSE:DGX) Stock Has Fared Decently: Is the Market Following Strong Financials?